Breaking Ground in MDS: Noteworthy Developments in 2024

Jamile Shammo, MD, of the Feinberg School of Medicine at Northwestern University, hosts a myelodysplastic syndromes (MDS) expert panel including Abdulraheem Yacoub, MD, of University of Kansas Medical Center; Tiffany Tanaka, MD, of the University of California, San Diego; and Keith W. Pratz, MD, of Abramson Cancer Center at the University of Pennsylvania. In this segment they discusses the past year in advances in MDS care and newly-presented ad hoc analysis on quality of life from the COMMANDS trial.